Abstract
ObjectiveCost-effectiveness of surveillance for branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) is debated. We combined different categories of risks of IPMN progression and of IPMN-unrelated mortality to improve surveillance strategies.DesignRetrospective analysis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have